BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7507675)

  • 1. FK506 conversion for intractable rejection of the liver allograft.
    McDiarmid SV; Klintmalm GB; Busuttil RW
    Transpl Int; 1993; 6(6):305-12. PubMed ID: 7507675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
    McDiarmid SV; Wallace P; Vargas J; Ament ME; Busuttil RW
    J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):291-9. PubMed ID: 7541834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience.
    Selzner N; Durand F; Bernuau J; Heneghan MA; Tuttle-Newhall JE; Belghiti J; Clavien PA
    Transplantation; 2001 Sep; 72(6):1061-5. PubMed ID: 11579301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 conversion therapy in pediatric liver transplantation.
    Egawa H; Esquivel CO; So SK; Cox K; Concepcion W; Lawrence L
    Transplantation; 1994 Apr; 57(8):1169-73. PubMed ID: 7513911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
    Demetris AJ; Fung JJ; Todo S; McCauley J; Jain A; Takaya S; Alessiani M; Abu-Elmagd K; Van Thiel DH; Starzl TE
    Transplantation; 1992 May; 53(5):1056-62. PubMed ID: 1374944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 rescue therapy for intractable liver allograft rejection.
    Wong P; Devlin J; Gane E; Ramage J; Portmann B; Williams R
    Transpl Int; 1994; 7 Suppl 1():S70-6. PubMed ID: 11271339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
    Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.
    Lancet; 1994 Aug; 344(8920):423-8. PubMed ID: 7520105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.
    Mazariegos GV; Salzedas AA; Jain A; Reyes J
    Paediatr Drugs; 2001; 3(9):661-72. PubMed ID: 11688597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from cyclosporin to FK 506 after liver transplantation.
    Winkler M; Ringe B; Jost U; Melter M; Rodeck B; Buhr T; Brinkmann C; Pichlmayr R
    Transpl Int; 1993; 6(6):319-24. PubMed ID: 7507677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children.
    Reggiani P; Gridelli B; Colledan M; Rossi G; Lucianetti A; Galmarini D; Fassati LR
    Transpl Int; 1998; 11 Suppl 1():S272-4. PubMed ID: 9664995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group.
    Sher LS; Cosenza CA; Michel J; Makowka L; Miller CM; Schwartz ME; Busuttil R; McDiarmid S; Burdick JF; Klein AS; Esquivel C; Klintmalm G; Levy M; Roberts JP; Lake JR; Kalayoglu M; D'Alessandro AM; Gordon RD; Stieber AC; Shaw BW; Thistlethwaite JR; Whittington P; Wiesner RH; Porayko M; Cosimi AB
    Transplantation; 1997 Jul; 64(2):258-63. PubMed ID: 9256184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.